Caricamento...
Initial Experience With Lung Cancer Resection Following Treatment With T Cell Checkpoint Inhibitor Therapy
T cell checkpoint inhibitors targeting the programmed death receptor-1 (PD-1) and its ligand (PDL-1) have recently been approved for the treatment of metastatic non-small cell lung cancer (NSCLC), but their safety and efficacy as neoadjuvant therapy are still undefined. Autoimmune toxicities, notabl...
Salvato in:
| Pubblicato in: | Ann Thorac Surg |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5572805/ https://ncbi.nlm.nih.gov/pubmed/28838509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2017.03.038 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|